Leadership
We have built a professional leadership team that has prolific experience in drug development and clinical research.
Composed of former senior executives from internationally renowned biopharmaceutical companies, clinical development experts, and key researchers from China pioneering in the translational research of genome editing technologies, the team excels in genome editing technology, drug development and manufacturing, clinical research, registration and application.
-
Dong Wei
Ph.D., MBA
Chief Executive Officer -
Pengfei Yuan
Ph.D.
Chief Technology Officer -
Yajun Si
MBA
Chief Operating Officer -
Yun Li
M.D.
Senior Vice President, Clinical Development -
Jia Shi
Ph.D.
Senior Director of Quality and Production -
Bo Zhang
Ph.D.
Head of US Subsidiary -
Kehua Fan
M.D.
VP of Business Development -
Jennifer Deng
Finance Director
